Taryn E. Gillies

Taryn E. Gillies

Auto-generated profile, based on publicly available information

Taryn E. Gillies

Nautilus Biotechnology, Inc., San Carlos, CA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Current Biology
Verified
Journal Article
Closed access
TGTaryn E. Gillies
Taryn E. Gillies
CCClemens Cabernard
Clemens Cabernard

24 July 2020 in Science
Verified
Journal Article
Closed access
DMDerek N. Macklin
Derek N. Macklin
TATravis A. Ahn-Horst
Travis A. Ahn-Horst
HCHeejo Choi
Heejo Choi
NRNicholas A. Ruggero
Nicholas A. Ruggero
JCJavier Carrera
Javier Carrera
MCMarkus W. Covert
Markus W. Covert
Testing biochemical data by simulation: Can a bacterial cell model vet large datasets from disparate sources? Macklin et al. explored whether a comprehensive mathematical model can be used to verify or find conflicts in massive amounts of data that have been reported for the bacterium Escherichia coli , produced in thousands of papers from hundreds of labs. Although most data were consistent, there were data that could not accommodate known biological results, such as insufficient output of RNA polymerases and ribosomes to produce measured cell-doubling times. Other analyses showed that for some essential proteins, no RNA may be transcribed or translated in a cell's lifetime, but viability can be maintained without certain enzymes through a pool of stable metabolites produced earlier. Science , this issue p. eaav3751

1 December 2017 in Cell Systems
Verified
Journal Article
Closed access
TGTaryn E. Gillies
Taryn E. Gillies
MPMichael Pargett
Michael Pargett
MMMarta Minguet
Marta Minguet
ADAlex E. Davies
Alex E. Davies
JAJohn G. Albeck
John G. Albeck

1 October 2020 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
TGTaryn E Gillies
Taryn E Gillies
MPMichael Pargett
Michael Pargett
JSJillian M Silva
Jillian M Silva
CTCarolyn K Teragawa
Carolyn K Teragawa
FMFrank McCormick
Frank McCormick
JAJohn G Albeck
John G Albeck
Activating mutations in RAS are present in ~ 30% of human tumors, and the resulting aberrations in ERK/MAPK signaling play a central role in oncogenesis. However, the form of these signaling changes is uncertain, with activating RAS mutants linked to both increased and decreased ERK activation in vivo . Rationally targeting the kinase activity of this pathway requires clarification of the quantitative effects of RAS mutations. Here, we use live‐cell imaging in cells expressing only one RAS isoform to quantify ERK activity with a new level of accuracy. We find that despite large differences in their biochemical activity, mutant KRAS isoforms within cells have similar ranges of ERK output. We identify roles for pathway‐level effects, including variation in feedback strength and feedforward modulation of phosphatase activity, that act to rescale pathway sensitivity, ultimately resisting changes in the dynamic range of ERK activity while preserving responsiveness to growth factor stimuli. Our results reconcile seemingly inconsistent reports within the literature and imply that the signaling changes induced by RAS mutations early in oncogenesis are subtle.

21 July 2017
Verified
Book Chapter
Closed access
PDF file
MPMichael Pargett
Michael Pargett
TGTaryn E. Gillies
Taryn E. Gillies
CTCarolyn K. Teragawa
Carolyn K. Teragawa
BSBreanne Sparta
Breanne Sparta
JAJohn G. Albeck
John G. Albeck

1 November 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MKMichael Kirmiz
Michael Kirmiz
TGTaryn E. Gillies
Taryn E. Gillies
EDEamonn J. Dickson
Eamonn J. Dickson
JTJames S. Trimmer
James S. Trimmer
The association of plasma membrane (PM)-localized voltage-gated potassium (Kv2) channels with endoplasmic reticulum (ER)-localized vesicle-associated membrane protein-associated proteins VAPA and VAPB defines ER–PM junctions in mammalian brain neurons. Here, we used proteomics to identify proteins associated with Kv2/VAP-containing ER–PM junctions. We found that the VAP-interacting membrane-associated phosphatidylinositol (PtdIns) transfer proteins PYK2 N-terminal domain-interacting receptor 2 (Nir2) and Nir3 specifically associate with Kv2.1 complexes. When coexpressed with Kv2.1 and VAPA in HEK293T cells, Nir2 colocalized with cell-surface–conducting and -nonconducting Kv2.1 isoforms. This was enhanced by muscarinic-mediated PtdIns(4,5)P2 hydrolysis, leading to dynamic recruitment of Nir2 to Kv2.1 clusters. In cultured rat hippocampal neurons, exogenously expressed Nir2 did not strongly colocalize with Kv2.1, unless exogenous VAPA was also expressed, supporting the notion that VAPA mediates the spatial association of Kv2.1 and Nir2. Immunolabeling signals of endogenous Kv2.1, Nir2, and VAP puncta were spatially correlated in cultured neurons. Fluorescence-recovery-after-photobleaching experiments revealed that Kv2.1, VAPA, and Nir2 have comparable turnover rates at ER–PM junctions, suggesting that they form complexes at these sites. Exogenous Kv2.1 expression in HEK293T cells resulted in significant differences in the kinetics of PtdIns(4,5)P2 recovery following repetitive muscarinic stimulation, with no apparent impact on resting PtdIns(4,5)P2 or PtdIns(4)P levels. Finally, the brains of Kv2.1-knockout mice had altered composition of PtdIns lipids, suggesting a crucial role for native Kv2.1-containing ER–PM junctions in regulating PtdIns lipid metabolism in brain neurons. These results suggest that ER–PM junctions formed by Kv2 channel–VAP pairing regulate PtdIns lipid homeostasis via VAP-associated PtdIns transfer proteins.